Special edition: Pre- and probiotics

Mature markets seeing beyond probiotics’ ‘balance microflora’ benefits: Lallemand

"Gut health remains our major field of application, but as we discover the variety of mechanisms of action of probiotics, their array of health benefits has also widened. First immunity, then the brain-gut axis, with great potential in stress and anxiety,” said Bérengère Feuz, marketing group manager for Lallemand Health Solutions.

The market for probiotic supplements and food continues to grow at a fast clip worldwide, expected to reach $45bn by 2017 (up from $30bn in 2012), according to Euromonitor. Global ingredient supplier Lallemand Health Solutions is no stranger to this market, with close to 40 documented probiotic strains in its portfolio and 80 years under its belt.

“Gut health is both historically and in terms of scientific documentation the primary target for probiotics, and remains our major field of application,” Bérengère Feuz, marketing group manager for Lallemand Health Solutions, told NutraIngredients-USA. “But as we discover the variety of mechanisms of action of probiotics, their array of health benefits has also widened. First immunity, then the brain-gut axis, with great potential in stress and anxiety.”

In less mature markets, gut health, including antibiotic-associated diarrhea, acute diarrhea for instance due to C. difficile, IBS, etc., remains the core benefit expected from a probiotic product. Unsurprisingly, in the more developed markets of North America and Europe, mindful consumers are starting to look beyond the “balance microflora” feature to more cutting-edge benefits. “For example, immunity modulation is gaining momentum,” she said.

Immunity modulation, stress control gain traction in developed markets

Indeed, on the heels of last year’s health claims approvals in Canada for ProbioKid (boosts body's natural defenses in children), Probio’Stick (reduces stress-related GI complications), Protectflor (reduces risk of traveler’s diarrhea), Lacidofil (restores and maintains intestinal flora), and Lalflor (reduces risk of antibiotic-associated diarrhea), Feuz said the most enthusiastic response thus far has been surrounding stress control.

“We are the first company demonstrate—in human clinical trials—a significant reduction of psychological stress without the side effects of drugs, with a good safety profile and no habituation,” she said. “However, there is still plenty of room for new formulations bringing strong health benefits to consumers in terms of gut health and immunity, and those are still the areas where we have most requests from our partners.”

That’s one of the reasons Lallemand has launched a systematic characterization program of its entire portfolio of probiotic strains, which involves studying their various modes of action, enabling it to customize formulations to address new areas such as oral care and women’s health.

“It is critical to be able to bring differentiated benefits with specific targets—for instance, a specific age group, or women’s health, or specific conditions such as IBS,” Feuz noted.

As the probiotic market continues to mature alongside global economies, the introduction of new technologies are facilitating a much better understanding of probiotics’ different modes of action and opening doors to new applications, Feuz said. “Ambitious programs such as meta-genome are also paving the way for new fields of application such as metabolic syndromes or obesity,” she added. “Let’s just say we have a wealth of possibilities ahead.”

Related News

A fifth (20%) of Americans say they are incorporating probiotics regularly, while some 29% say they have changed their diet to add more yogurt and fiber-rich foods to manage their digestive health, Mintel found.

Probiotics, fiber continue to steal market share from GI remedies

Starbucks won by identifying an unstated desire on the part of consumers for a coffee 'experience,' Leighton says.

Predictive data analysis can help companies become 'market makers,' consultant says

Symprove for IBS: Findings showed an improvement in abdominal pains and bowel habits associated with irritable bowel syndrome

Symprove for IBS: The medical fraternity are now taking us seriously, says chairman

Evidence of gut/brain connection piles up, but actual products are a ways off, researcher says

Evidence of gut/brain connection piles up, but actual products are a ways off, researcher says

Professor Gregor Reid will chair Probiota 2014 in Amsterdam on February 4-5. Expect to be challenged...

Fed up: Probiotic research veteran issues global call to action

Probiotic boosts flavonoids in fermented soy

Probiotic boosts flavonoids in fermented soy

36% of global yoghurt products are probiotic, says Euromonitor's Ewa Hudson

Global probiotic market to add 50% to €33bn by 2018: Analyst

“The fact that researchers isolated a strain of bacteria from kimchi and found it had this influence on brain neuropeptides is remarkable, highlighting that there may be other untold effects. That’s just one microbe from one fermented Asian dish,” said Alan C. Logan, co-author

Study urges more exploration of fermented foods’ yet untold benefits

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.